[go: up one dir, main page]

BR8302502U - Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease - Google Patents

Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease

Info

Publication number
BR8302502U
BR8302502U BR8302502U BR8302502U BR8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U
Authority
BR
Brazil
Prior art keywords
treatment
individuals
packaging
drug
presentation
Prior art date
Application number
BR8302502U
Other languages
Portuguese (pt)
Inventor
Alexandre Funari Negrao
Original Assignee
Medley S A Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medley S A Ind Farmaceutica filed Critical Medley S A Ind Farmaceutica
Priority to BR8302502U priority Critical patent/BR8302502U/en
Priority to PCT/BR2004/000089 priority patent/WO2004108056A2/en
Publication of BR8302502U publication Critical patent/BR8302502U/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"EMBALAGEM. OU KIT DE MEDICAMENTOS. OU APRESENTAçãO FACILITADORA DA ADMINISTRAçãO DE MEDICAMENTOS POR PARTE DE INDIVìDUOS EM PREVENçãO E/OU TRATAMENTO DA DOENçA ATEROSCLERóTICA".O presente Modelo de Utilidade trata de embalagem, ou kit de medicamentos, ou apresentação facilitadora da administração de medicamentos por parte de indivíduos em tratamento caracterizados por compreender em cada cartela, cartucho, blíster ou similar, um ou mais agentes antiplaquetários, antiinflamatórios ou apresentando atividade fibrinolítica positiva conjuntamente com um ou mais agentes capazes de melhor o perfil lipídico do sangue, e opcionalmente um ou mais medicamentos conhecidos do homem da técnica para esse tipo de tratamento, apresentados de forma didática, clara e segura, orientações informações ao paciente quanto à natureza ou tipo do princípio ativo, dosagem, quantidade de unidades de medicamentos, período do dia a ser tomada, assim como periodicidade do tratamento, ou outras informações, ou ainda segundo as FIGURAS 1 E 2."PACKAGING. OR MEDICINAL PRODUCTS KIT. OR EASY PRESENTATION OF MEDICINAL PRODUCTS ADMINISTRATION AND / OR TREATMENT OF INDIVIDUALS." medicaments by subjects in treatment characterized in that each card, cartridge, blister or the like comprises one or more antiplatelet, anti-inflammatory or positive fibrinolytic activity together with one or more agents capable of improving the blood lipid profile, and optionally one. or more drugs known to the man of the art for this type of treatment, presented in a didactic, clear and safe manner, guidance to the patient as to the nature or type of active ingredient, dosage, number of units of medication, time of day to be taken. as well as the periodicity of treatment, or the other information, or according to FIGURES 1 AND 2.

BR8302502U 2003-06-10 2003-06-10 Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease BR8302502U (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR8302502U BR8302502U (en) 2003-06-10 2003-06-10 Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease
PCT/BR2004/000089 WO2004108056A2 (en) 2003-06-10 2004-06-09 Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR8302502U BR8302502U (en) 2003-06-10 2003-06-10 Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease

Publications (1)

Publication Number Publication Date
BR8302502U true BR8302502U (en) 2005-04-19

Family

ID=38895611

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8302502U BR8302502U (en) 2003-06-10 2003-06-10 Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease

Country Status (2)

Country Link
BR (1) BR8302502U (en)
WO (1) WO2004108056A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
US20020045184A1 (en) * 2000-10-02 2002-04-18 Chih-Ming Chen Packaging system
US20030013688A1 (en) * 2001-06-21 2003-01-16 Rene Belder Synergistic combination of pravastatin and aspirin and method
US6576256B2 (en) * 2001-08-28 2003-06-10 The Brigham And Women's Hospital, Inc. Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin

Also Published As

Publication number Publication date
WO2004108056A3 (en) 2008-01-10
WO2004108056A2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
Boateng Drug delivery innovations to address global health challenges for pediatric and geriatric populations (through improvements in patient compliance)
Younge et al. A prospective randomized pilot comparison of intranasal fentanyl and intramuscular morphine for analgesia in children presenting to the emergency department with clinical fractures
Herson et al. Magical thinking and imipramine poisoning in two school-aged children
BR0116653A (en) Medicinal product containing a polyamine as active substance
BR8302502U (en) Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease
Ezechukwu et al. Drug Treatment Of Common Childhood Symptoms In Nnewi South Eastern Nigeria: What Mothers Do?
BR8300543U (en) Packaging, or drug kit, or patient-friendly presentation of drug administration
KR200255738Y1 (en) Aid box for taking prescribed medicine
Zidd et al. Pediatric ingestion of lamotrigine
JP2004526791A5 (en)
Hartman et al. Influence of advertising on the assortment of OTC cold medications
Hodgetts Falls in the Elderly: Assessment and prevention in the community
Cavalieri Adding life to the elder years
Cohen Double trouble
BR0303794A (en) Medication, Medication Kit, Medication Set, Medication Association and Medication Presenting Facilitated Presentation
Syrup Allanhist PDX Syrup and Oxtellar XR
Strength Diphenhydramine Oral Solution and Mucinex DM Maximum Strength
Capsules Loxapine Capsules and Mucinex DM Maximum Strength
Siltussin Siltussin DM and Valerian Root
Gever Drug challenge
Fund Tablets
Tablets Norvir Tablets and Poly-Tussin DM
WO2003013522A1 (en) Preventives/remedies for cholinergic neuropathy
Montalto Update on treatment of influenza A and B with Tamiflu
Cold Butisol Sodium and Pedia Care Multi-Symptom Cold

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MEDLEY INDUSTRIA FARMACEUTICA LTDA (BR/SP)

Free format text: ALTERADO DE: MEDLEY S.A. INDUSTRIA FARMACEUTICA

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 9O E 14 DA LPI

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.